ABWM
GMAB icon

Alpine Bank Wealth Management’s Genmab GMAB Stock Holding History

Alpine Bank Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-709
Closed -$13.9K – 426
2025
Q1 		$13.9K Buy
+709
New +$14.9K ﹤0.01% 364
2024
Q3 		$17.3K Buy
+709
New +$19K ﹤0.01% 371

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alpine Bank Wealth Management's GMAB Position: Q2 2025 in Review

Alpine Bank Wealth Management sold out of Genmab (GMAB) in Q2 2025, closing a stake of 709 shares — an estimated $13.9K sold.

Alpine Bank Wealth Management first reported a position in GMAB in Q3 2024 and held it in 2 quarters. The position peaked at $17.3K in Q3 2024. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Alpine Bank Wealth Management reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Alpine Bank Wealth Management sold 709 Genmab shares in Q2 2025, an estimated $13.9K.
  • Alpine Bank Wealth Management first reported a position in Genmab in Q3 2024 and held it in 2 quarters.
  • Alpine Bank Wealth Management's Genmab position peaked at $17.3K in Q3 2024.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.